Effectiveness of a psychoeducation group intervention conducted by primary healthcare nurses in patients with depression and physical comorbidity: study protocol for a randomized, controlled trial

Rocío Casañas, Jaume Martín Royo, Maria Isabel Fernandez-San-Martín, Antonia Raya Tena, Jacobo Mendioroz, Glòria Sauch Valmaña, Roser Masa-Font, Marc Casajuana-Closas, Eva María Fernandez Linares, Cèlia Cols-Sagarra, Susana Gonzalez Tejón, Quintí Foguet-Boreu, Luis Miguel Martín Lopez, Rocío Casañas, Jaume Martín Royo, Maria Isabel Fernandez-San-Martín, Antonia Raya Tena, Jacobo Mendioroz, Glòria Sauch Valmaña, Roser Masa-Font, Marc Casajuana-Closas, Eva María Fernandez Linares, Cèlia Cols-Sagarra, Susana Gonzalez Tejón, Quintí Foguet-Boreu, Luis Miguel Martín Lopez

Abstract

Background: Depressive disorders are the third leading cause of consultation in primary care, mainly in patients with chronic physical illnesses. Studies have shown the effectiveness of group psychoeducation in reducing symptoms in depressive individuals. Our primary aim is to evaluate the effectiveness of an intervention based on a psychoeducational program, carried out by primary care nurses, to improve the remission/response rate of depression in patients with chronic physical illness. Secondarily, to assess the cost-effectiveness of the intervention, its impact on improving control of the physical pathology and quality of life, and intervention feasibility.

Methods/design: A multicenter, randomized, clinical trial, with two groups and one-year follow-up evaluation. Economic evaluation study.

Subjects: We will assess 504 patients (252 in each group) aged > 50 years assigned to 25 primary healthcare centers (PHC) from Catalonia (urban, semi-urban, and rural). Participants suffer from major depression (Beck depression inventory: BDI-II 13-28) and at least one of the following: type 2 diabetes mellitus, chronic obstructive pulmonary disease, asthma, and/or ischemic cardiopathy. Patients with moderate/severe suicide risk or severe mental disorders are excluded. Participants will be distributed randomly into the intervention group (IG) and control (CG).

Intervention: The IG will participate in the psychoeducational intervention: 12 sessions of 90 min, once a week led by two Primary Care (PC) nurses. The sessions will consist of health education regarding chronic physical illness and depressive symptoms.

Main measurements: Clinical remission of depression and/or response to intervention (BDI-II).

Secondary measurements: Improvement in control of chronic diseases (blood test and physical parameters), drug compliance (Morinsky-Green test and number of containers returned), quality of life (EQ-5D), medical service utilization (appointments and hospital admissions due to complications), and feasibility of the intervention (satisfaction and compliance). Evaluations will be blinded, and conducted at baseline, post-intervention, and 12 months follow-up.

Discussion: Results could be informative for efforts to prevent depression in patients with a chronic physical illness.

Trial registration: NCT03243799 (registration date August 9, 2017).

Keywords: Chronic physical illness; Depression; Nurses; Primary healthcare; Psychoeducation.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442.
    1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–1078. doi: 10.2337/diacare.24.6.1069.
    1. Salvador-Carulla L, Bendeck M, Fernández A, Albertí C, Sabes-Figuera R, Molina C, Knapp M. Costs of depression in Catalonia (Spain) J Affect Disord. 2011;132:130–138. doi: 10.1016/j.jad.2011.02.019.
    1. Benton T, Staab J, Evans DL. Medical co-morbidity in depressive disorders. Ann Clin Psychiatry. 2007;19(4):289–303. doi: 10.1080/10401230701653542.
    1. Rucci P, Gherardi S, Tansella M, Piccinelli M, Berardi D, Bisoffi G, et al. Corsino MA, Pini S. subthreshold psychiatric disorders in primary care: prevalence and associated characteristics. J Affect Disord. 2003;76:171–181. doi: 10.1016/S0165-0327(02)00087-3.
    1. World Health Organization. Depression and other common mental disorders: global health estimates. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. .
    1. World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008. . Accessed 27 June 2013.
    1. Nobis S, Lehr D, Ebert DD, Baumeister H, Snoek F, Riper H, Berking M. Efficacy of a web-based intervention with mobile phone support in treating depressive symptoms in adults with type 1 and type 2 diabetes: a randomized controlled trial. Diabetes Care. 2015;38(5):776–783. doi: 10.2337/dc14-1728.
    1. National Collaborating Centre for Mental Health. NICE clinical guidelines 91-depression in adults with a chronic physical health problem: recognition and management. London: National Institute for Health and Clinical Excellence; 2009. .
    1. Van Dijk S, Pols Alide D, Adriaanse M, Bosmans J, Elders PJM, van Marwijk H, van Tulder M. Cost-effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: design of a cluster-randomized controlled trial. BMC Psychiatry. 2013;13:128. doi: 10.1186/1471-244X-13-128.
    1. Reynolds CF, 3rd, Cuijpers P, Patel V, Cohen A, Dias A, Chowdhary N, Okereke OI, Dew MA, Anderson SJ, Mazumdar S, Lotrich F, Albert SM. Early intervention to reduce the global health and economic burden of major depression in older adults. Annu Rev Public Health. 2012;33:123–135. doi: 10.1146/annurev-publhealth-031811-124544.
    1. Stoop CH, Nefs G, Pommer AM, Pop VJ, Pouwer F. Effectiveness of a stepped care intervention for anxiety and depression in people with diabetes, asthma or COPD in primary care: a randomized controlled trial. J Affect Disord. 2015;184:269–276. doi: 10.1016/j.jad.2015.05.063.
    1. Pibernik-Okanovic M, Begic D, Ajdukovic D, Andrijasevic N, Metelko Z. Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial. Trials. 2009;10:78. doi: 10.1186/1745-6215-10-78.
    1. Pibernik-Okanović M, Hermanns N, Ajduković D, Kos J, Prašek M, Šekerija M, Lovrenčić MV. Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual. Trials. 2015;16:305. doi: 10.1186/s13063-015-0833-8.
    1. Schmitt A, Reimer A, Ehrmann D, Kulzer B, Haak T, Hermanns N. Reduction of depressive symptoms predicts improved glycaemic control: secondary results from the DIAMOS study. J Diabet Complicat. 2017;31(11):1608–1613. doi: 10.1016/j.jdiacomp.2017.08.004.
    1. Cuijpers Pim, Andersson Gerhard, Donker Tara, van Straten Annemieke. Psychological treatment of depression: Results of a series of meta-analyses. Nordic Journal of Psychiatry. 2011;65(6):354–364. doi: 10.3109/08039488.2011.596570.
    1. Tursi MF, Baes CV, Camacho FR, Tofoli SM, Juruena MF. Effectiveness of psychoeducation for depression: a systematic review. Aust N Z J Psychiatry. 2013;47:1019. doi: 10.1177/0004867413491154.
    1. Casañas R, Catalán R, del Val JL, Real J, Valero S, Casas M. Effectiveness of a psycho-educational group program for major depression in primary care:a randomized controlled trial. BMC Psychiatry. 2012;12:230. doi: 10.1186/1471-244X-12-230.
    1. Cuijpers P, Muñoz RF, Clarke GN, Lewinsohn PM. Psychoeducational treatment and prevention of depression: the “coping with depression” course thirty years later. Clin Psychol Rev. 2009;29:449–458. doi: 10.1016/j.cpr.2009.04.005.
    1. Dalgard OS. A randomized controlled trial of a psychoeducational group program for unipolar depression in adults in Norway (NCT00319540) Clin Pract Epidemiol Ment Health. 2006;2:15. doi: 10.1186/1745-0179-2-15.
    1. Beck AT, Ward CH, Mendelson M, et al. Inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004.
    1. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100. doi: 10.1016/0272-7358(88)90050-5.
    1. Sanz J, Perdigon LA, Vazquez C. Adaptación española del Inventario para la Depresion de Beck G (BDI-II): 2.Propiedades psicométricas en población general. Clin Salud. 2003;14(3):249–280.
    1. Sanz J, Garcia-Vera MP, Espinosa R, Fortun M, Vazquez C. Adaptación española del Inventario para la Depresion de Beck G (BDI-II): 3. Propiedades psicométricas en pacientes con trastornos psicológicos. Clín Salud. 2005;16(2):121–142.
    1. Sanz J, Garcia-Vera MP. Rendimiento diagnóstico y estructura factorial del Inventario de Depresion de Beck-II (BDI-II) Anal Psicol. 2013;29(1):66–75.
    1. Grup de treball del Programa de sessions grupals psicoeducatives per a l’estudi sobre l’efectivitat d’una intervenció grupal psicoeducativa realitzada per infermeres d’atenció primària en pacients amb depressió i comorbiditat física (Estudi PsiCoDep). PI16/01272 i PERIS SLT002/17/00096.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 2):22–33.
    1. Ferrando L, Bobes J, Gibert J. Mini International Neuropsychiatric Interview (M.I.N.I., Version Española 5.0.0 DSM-IV). Madrid: Instituto IAP; 2000. Accesible a través de: .
    1. World Health Organization. Guiá de bolsillo de la clasificació n CIE-10 : clasificació n de los trastornos mentales y del comportamiento. Madrid: Editorial Médica Panamericana; 2000.
    1. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23(10):433–441. doi: 10.1111/j.1532-5415.1975.tb00927.x.
    1. Martinez de la Iglesia J, Duenas Herrero R, Onis Vilches MC, Aguado Taberne C, Albert Colomer C, Luque Luque R. Adaptación y validación al castellano del cuestionario de Pfeiffer (SPMSQ) para detectar la existenica de deterioro cognitivo en personas mayores de 65 años. Med Clin (Barc) 2001;117(4):129–134. doi: 10.1016/S0025-7753(01)72040-4.
    1. Riedel M, Möller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, et al. Response and remission criteria in major depression. A validation of current practice. J Psychiatr Res. 2010;44:1063–1068. doi: 10.1016/j.jpsychires.2010.03.006.
    1. Práctica clínica en la DM2. Análisis crítico de las evidencias por la redGDPS. 2011. . Guía de Práctica Clínica sobre Diabetes tipo 2. Guías de Práctica Clínica en el SNS. Ministerio de Sanidad y Consumo 2008.
    1. Casal M, Pinal-Fernández I. Guía de Práctica Clínica de Diabetes tipo 2. Arch Med. 2014;10(2):2. 10.3823/1212, .
    1. Grupo de trabajo de la Guía de Práctica Clínica para el Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC). Guía de Práctica Clínica para el Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica. (EPOC). Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad, Servicios Sociales e Igualdad. Unidad de Evaluación de Tecnologías Sanitarias de la Agencia Laín Entralgo; 2012. Guías de Práctica Clínica en el SNS: UETS N° 2011/6. Disponible en: .
    1. Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC).Guía Española de la EPOC (GesEPOC). Grupo de Trabajo de GesEPOC. Arch Bronconeumol. 2012; 48(Supl 1):2–58. .
    1. GEMA. Guía Española para el Manejo del Asma 2009. .
    1. Guía de Práctica Clínica de la ESC 2013 sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Grupo de Trabajo de la Sociedad Europea de Cardiologia sobre diagnóstico y tratamiento de la cardiopatía isquémica estable Rev Esp Cardiol 2014;67(2):135.e1-135e81.
    1. Val Jiménez A, Amorós G, Martínez P, Fernández ML, León M. Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test de Morisky-Green. Aten Primaria. 1992;10:767–770.
    1. Group EQ EuroQol- a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin. 1999;112(Suppl 1):79–86.
    1. Lobo A, Chamorro L, Luque A, Dal-Ré R, Badia X, Baró E. Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad. Med Clin (Barc) 2002;118(13):480–520. doi: 10.1016/S0025-7753(02)72429-9.
    1. Oblikue consulting. Disponible en: .
    1. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27(3 Suppl):S178–S189. doi: 10.1097/00005650-198903001-00015.
    1. Drummond MF, O'Brian B, Stoddart GL, Torrance GW. Methods for the economic evaluation of heathcare programmes. 2. Oxford: Oxford University Press; 1997.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅